NCT02717689 - A Pragmatic Trial of Corticosteroid Optimisation in Severe Asthma | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

June 19, 2019

Study Completion Date

June 19, 2019

Conditions

Severe Persistent Asthma

Interventions

OTHER

Biomarker based adjustment of corticosteroid dose

The subject's corticosteroid dose will be adjusted based upon biomarker results (FeNO, eosinophils and periostin)

Trial Locations (11)

Belfast Health and Social Care Trust, Belfast

Heart of England NHS Foundation Trust, Birmingham

NHS Greater Glasgow and Clyde, Glasgow

University Hospitals of Leicester NHS Trust, Leicester

Royal Brompton & Harefield NHS Foundation Hospital, London

University College London Hospitals NHS Foundation, London

University Hospitals of South Manchester NHS Trust, Manchester

Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne

Nottingham University Hospitals NHS Foundation Trust, Nottingham

Oxford University Hospitals NHS Trust, Oxford

University Hospital of Southampton NHS Foundation Trust, Southampton